Copa Airlines Magazine Features Stem Cell Therapy at the Stem Cell Institute in Panama

Clinical Trials for Multiple Sclerosis and Rheumatoid Arthritis using Umbilical Cord Tissue Mesenchymal Stem Cells

Stem Cell Institute and Medistem Panama founder, Neil Riordan, PhD discusses clinical trials for multiple sclerosis and rheumatoid arthritis using umbilical cord tissue-derived mesenchymal stem cells at our fall stem cell seminar in San Antonio.

For more information about these trials and others, please visit www.translationalbiosciences.com. The multiple sclerosis trial is full but the RA trial is still recruiting as of November 24, 2014.

Highlights include:

How do we select umbilical cords for use? Medistem has identified proteins and genes in the cells that allow us to screen hundreds of umbilical cords to select only the ones containing the specific types of cells that have the best anti-inflammatory properties, the best immune modulating capacity and the best ability to stimulate regeneration.

How therapy using umbilical cord tissue-derived mesenchymal stem cells (MSCs) differs from bone marrow transplants used in cancer patients.

Properties of umbilical cord MSCs:

  • Modulate the immune system
  • Increase the number of T-regulatory cells
  • Block clonal expansion of activated T cells
  • MSCs in patients with autoimmune diseases don’t work properly

How demyelination occurs in MS patients and how MSCs act on the immune system to slow it down or stop it.

Treated MS patient follow-up survey results at 120 days and 1 year after treatment.

Television news story about Sam Harrell’s return to coaching football after severe MS symptoms forced him into early retirement.

Results from a 172 patient study on treating rheumatoid arthritis with intravenous umbilical cord tissue mesenchymal stem cells in which all patients improved.

Trial Information

These trials may be viewed on the National Institutes of Health web site www.clinicaltrials.gov

Umbilical Cord Tissue-derived Mesenchymal Stem Cells for Rheumatoid Arthritis

Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis

Those interested in stem cell therapy for MS may still apply for private treatment on this site.

A Review of Therapeutic Effects of Mesenchymal Stem Cell Secretions and Induction of Secretory Modification by Different Culture Methods

Another competitive ballroom dancer back in the game after stem cell therapy

Emerald IEditor’s Note: Deborah received human umbilical cord tissue-derived mesenchymal stem cells

My name is Deborah, from Southern California.

Occupation: Certified Interior Designer with a Masters degree in Interior Design.

Diagnosis: Patella chondromalacia with thinning of cartilage, mostly involving the medial facet and at the median. There is early degenerative changes with small marginal spurs involving the femoral patellar compartment and the medial and lateral femorotibial compartments. There is no fracture, osteochondral or loose body. Also localized inflammation of the Hoffa’s fat pad, anterior to the transverse. (All of these findings were from an MRI taken on June 15, 2011).

Symptoms before treatment: severe pain, difficulty in walking, bending, standing, sitting, exercising, sleeping…life was not fun.

Treatments/drugs: Aleve, Tylenol, Celebrex, acupuncture, physical therapy, custom brace, ace elastic braces, interviewed /consults with three independent orthopedic surgeons, possible knee replacement, arthroscopic surgery to mend torn meniscus.

My friend and ballroom dance competitor, Dr. Janet Vaughan convinced me after I had been researching other alternatives here in the United States for over a year, to contact Dr. Barnett at the Stem Cell Institute in Panama City, Panama to see if I was a candidate for stem cell therapy. Janet was kind enough to email Dr. Barnett for me and tell her I would be filling out the paperwork online and sending it to her ASAP. Dr. Barnett was extremely responsive and my husband and I soon had a conference call with Dr. Paz Rodriguez. He was kind, gracious and patient with all of our questions. We were soon on our way with an appointment to have stem cell therapy in Panama City, Panama!

I am now able to get back to my competitive ballroom dancing and doing well! I have less pain going up and down stairs (even though I am careful and always aware of my knees), I walk easier, exercise and am back to a normal life style. Am I at 100% ? No…but at 62 years old and being athletic all my life with snow skiing, water skiing, volleyball, tennis, racquetball, zoomba and other athletic movements I feel terrific even if I am at 80-90% of my capability! We are back to travelling the world and I am thrilled… I am living my life! And my knee is not dictating my life.

Impression of the clinic: The doctors, staff and driver, Javier were fabulous!!! Everyone made me and my husband feel comfortable and all were compassionate, personable, professional, helpful, friendly and always welcome to keep in touch! They always welcomed all of our questions and never made us feel uncomfortable in asking! Dr. Hernandez was with me all the way and gave me his cell number 24/7 and helped me through the language barrier since my Spanish is quiet weak! Everyone was just great!!!

What would I tell someone considering stem cell therapy: Do your homework… research and get referrals! You have nothing to lose and a life to gain! The Stem Cell Institute is terrific in their work and research! I have told many of my friends and individuals who find out through others that I had stem cell therapy. Unfortunately none have moved forward and try other options and still have no results…I feel sorry for them! Some do…and some do not.

Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in San Antonio, Texas September 20th, 2014

The Stem Cell Institute, located in Panama City, Panama, will present an informational seminar about umbilical cord stem cell therapy on Saturday, September 20, 2014 in San Antonio, Texas at the La Cantera Hill Country Resort from 1:00 pm to 4:00 pm.

San Antonio, TX (PRWEB) September 11, 2014

The Stem Cell Institute, located in Panama City, Panama, will present an informational seminar about umbilical cord stem cell therapy on Saturday, September 20, 2014 in San Antonio, Texas at the La Cantera Hill Country Resort from 1:00 pm to 4:00 pm.
Stem Cell Institute Speakers include:

Neil Riordan PhD – “Umbilical Cord Stem Cell Clinical Trials for MS and Autism: Rationale and Clinical Protocols”
Dr. Riordan is the founder of the Stem Cell Institute and Medistem Panama Inc.

Jorge Paz-Rodriguez MD
– “Umbilical Cord Stem Cell Therapy for Arthritis, Inflammation and Sports Injuries”
Dr. Paz is the Medical Director at the Stem Cell Institute. He practiced internal medicine in the United States for over a decade before joining the Stem Cell Institute in Panama.

Special Guest Speaker:
Janet Vaughan, DDS, MS, Professional Dancer – “Successful Stem Cell Therapy in Panama: A Patient’s Perspective”
Dr. Vaughan is Board Certified in Orthodontics (Diplomate of the American Board of Orthodontics) and she is a Fellow in the International College of Dentistry.

She is a U.S. national Dance Sport Champion, currently holding national titles in 16 divisions of ballroom dancing including numerous gold medals. She was previously the #1 Pro/Am Ballroom Dancer in the United States.

Light snacks will be served afterwards. Our speakers and stem cell therapy patients will be on hand to share their personal experiences and answer questions.

Admission is free but space in limited and registration is required. For venue information and to register and reserve your tickets today, please visit: http://www.eventbrite.com/e/stem-cell-institute-seminar-san-antonio-tickets-12029022129 or call Cindy Cunningham, Patient Events Coordinator, at 1 (800) 980-7836.

About Stem Cell Institute Panama
Founded in 2007 on the principles of providing unbiased, scientifically sound treatment options; the Stem Cell Institute (SCI) has matured into the world’s leading adult stem cell therapy and research center. In close collaboration with universities and physicians world-wide, our comprehensive stem cell treatment protocols employ well-targeted combinations of autologous bone marrow stem cells, autologous adipose stem cells, and donor human umbilical cord stem cells to treat: autism, cerebral palsy, multiple sclerosis, spinal cord injury, osteoarthritis, rheumatoid arthritis, heart disease, and autoimmune diseases.

In partnership with Translational Biosciences, a subsidiary of Medistem Panama, SCI provides clinical services for ongoing clinical trials that are assessing safety and signs of efficacy for autism, multiple sclerosis, osteoarthritis, rheumatoid arthritis, and spinal cord injury using allogeneic umbilical cord tissue-derived mesenchymal stem cells (hUC-MSC), autologous stromal vascular fraction (SVF) and hU-MSC-derived mesenchymal trophic factors (MTF). In 2014, Translation Biosciences expects to expand its clinical trial portfolio to include heart disease and cerebral palsy.

For more information on stem cell therapy:

Stem Cell Institute Website: http://www.cellmedicine.com

Stem Cell Institute
Via Israel & Calle 66
Plaza Pacific Office #2A
Panama City, Panama

About Medistem Panama Inc.
Since opening its doors in 2007, Medistem Panama Inc. has developed adult stem cell-based products from human umbilical cord tissue and blood, adipose (fat) tissue and bone marrow. Medistem operates an 8000 sq. ft. ISO 9001-certified laboratory in the prestigious City of Knowledge. The laboratory is fully licensed by the Panamanian Ministry of Health and features 3 class 10000 clean rooms, class 100 laminar flow hoods, and class 100 incubators.

Medistem Panama Website: http://www.medistempanama.com

Medistem Panama Inc.
Ciudad del Saber, Edif. 221 / Clayton
Panama, Rep. of Panama

Phone: +507 306-2601
Fax: +507 306-2601

About Translational Biosciences
A subsidiary of Medistem Panama Inc., Translational Biosciences was founded solely to conduct clinical trials using adult stem cells and adult stem cell-derived products.

Translational Biosciences Web Site: http://www.translationalbiosciences.com

Stem Cell Therapy: Paralyzed Whitfield Co teen takes first steps, community pitching in

Posted: May 02, 2014 4:57 PM CDT Updated: May 02, 2014 6:05 PM CDT
By Kimberly Barbour, Reporter

Hannah LockeWHITFIELD COUNTY, GA (WRCB) – A North Georgia community is rallying around a teen girl recovering from a head-on car crash. She recently took her first steps since becoming paralyzed one year ago.

17-year-old Hannah Locke was riding in her family’s car last April when another car hit them head-on. She’s been confined to a wheelchair ever since, but now, a breakthrough.

Her community is trying to raise money for more treatment in hopes she’ll be able to walk on her own again someday.

Hannah is a junior at Coahulla Creek High School. Before the paralyzing accident she was a three sport athlete. Now her drive has shifted to getting out of the wheelchair she’s been in for the last year. She says it’s with her faith and community that she’s getting closer reaching that goal. Her friends are hoping to give her a boost this weekend.

It’s been a year full of challenges far beyond most teens, but Hannah Locke is only growing stronger.

She recently took her first steps since becoming paralyzed one year after a head-on crash. In just the last month, she’s re-gained some control over the lower half of her body.

“They laid me down and told me to try to kick my legs and they did it and we were all like, what just happened,” Hannah said.

Now she’s walking with a harness.

“Feeling emotion-wise, it’s exciting but feeling-wise, it’s weird to see my feet moving and not really be in complete control over them or feel them,” Hannah said.

“I don’t think we’ve ever been filled with so much joy before because I know how hard she works on a daily basis whether it’s therapy or here at home just getting out of bed, doing normal things me and you do that’s so much harder for her,” friend Jordan Greene said.

Hannah says people throughout Whitfield County have been there holding her hand through it all. They’ve held fundraisers to help pay some of her medical expenses, but this weekend they’re going bigger. They’ve organized a benefit concert featuring Christian musicians and some cast members from the show Duck Dynasty.

“People throughout the community were just like oh you need posters, we’ll print them, oh you need t-shirts we’ll do that, oh you need a gym, come use ours,” Greene said.

The money will pay for a return trip to Panama where Hannah hopes to get more stem cell injections that are helping re-connect the nerves in her legs.

Those who know her say they’ll do everything they can to get her back on her feet again. They say she’s a girl who inspires everyone she meets with her positive attitude and unwavering faith in God.

“He always finds a way to shine a light in the toughest storms,” Hannah said.

The concert is 5:30 p.m. Sunday at North Murray High School. Doors open at 4:45 p.m. They still half the seats available and will still be selling them at the door. General admission is $30 and floor preferred tickets are $60. For more info, call 800-965-9324 or email helpinghannahheal@gmail.com

“I am riding my bike 10 miles a day, swimming, walking…all virtually PAIN FREE!” – Debra Deuble

We received this message from Debra Deuble yesterday. Debra gave us the ok to share it with everyone.

“I am a stem cell recipient from your clinic in Panama! I am grateful every day that I had this done. It has been over a year and I have not been on any medications and I feel great! I am riding my bike 10 miles a day, swimming, walking…all virtually PAIN FREE! I feel like I have had the fountain of youth! I was diagnosed with severe Rheumatoid Arthritis. I was 37 when I had symptoms and 46 when diagnosed. Was on meds for 7 years and nothing helped. So glad I found your website in my search for a cure!!”

Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in New York City May 17th, 2014

New York, NY (PRWEB) April 09, 2014

The Stem Cell Institute, located in Panama City, Panama, will present an informational umbilical cord stem cell therapy seminar on Saturday, May 17, 2014 in New York City at the New York Hilton Midtown from 1:00 pm to 4:00 pm.

Speakers include:

Neil Riordan PhD“Clinical Trials: Umbilical Cord Mesenchymal Stem Cell Therapy for Autism and Spinal Cord Injury”

Dr. Riordan is the founder of the Stem Cell Institute and Medistem Panama Inc.

Jorge Paz-Rodriguez MD“Stem Cell Therapy for Autoimmune Disease: MS, Rheumatoid Arthritis and Lupus”

Dr. Paz is the Medical Director at the Stem Cell Institute. He practiced internal medicine in the United States for over a decade before joining the Stem Cell Institute in Panama.

Light snacks will be served afterwards. Our speakers and stem cell therapy patients will also be on hand to share their personal experiences and answer questions.

Admission is free but space in limited and registration is required. For venue information and to register and reserve your tickets today, please visit: http://www.eventbrite.com/e/stem-cell-institute-seminar-tickets-11115112601 or call Cindy Cunningham, Patient Events Coordinator, at 1 (800) 980-7836.

About Stem Cell Institute Panama
Founded in 2007 on the principles of providing unbiased, scientifically sound treatment options; the Stem Cell Institute (SCI) has matured into the world’s leading adult stem cell therapy and research center. In close collaboration with universities and physicians world-wide, our comprehensive stem cell treatment protocols employ well-targeted combinations of autologous bone marrow stem cells, autologous adipose stem cells, and donor human umbilical cord stem cells to treat: multiple sclerosis, spinal cord injury, osteoarthritis, rheumatoid arthritis, heart disease, and autoimmune diseases.

In partnership with Translational Biosciences, a subsidiary of Medistem Panama, SCI provides clinical services for ongoing clinical trials that are assessing safety and signs of efficacy for osteoarthritis, rheumatoid arthritis, and multiple sclerosis using allogeneic umbilical cord tissue-derived mesenchymal stem cells (hUC-MSC), autologous stromal vascular fraction (SVF) and hU-MSC-derived mesenchymal trophic factors (MTF). In 2014, Translation Biosciences expects to expand its clinical trial portfolio to include spinal cord injury, heart disease, autism and cerebral palsy.

To-date, SCI has treated over 2000 patients.

For more information on stem cell therapy:

Stem Cell Institute Website: http://www.cellmedicine.com

Stem Cell Institute
Via Israel & Calle 66
Plaza Pacific Office #2A
Panama City, Panama

About Medistem Panama Inc.
Since opening its doors in 2007, Medistem Panama Inc. has developed adult stem cell-based products from human umbilical cord tissue and blood, adipose (fat) tissue and bone marrow. Medistem operates an 8000 sq. ft. ISO 9001-certified laboratory in the prestigious City of Knowledge. The laboratory is fully licensed by the Panamanian Ministry of Health and features 3 class 10000 clean rooms, class 100 laminar flow hoods, and class 100 incubators.

Medistem Panama Inc.
Ciudad del Saber, Edif. 221 / Clayton
Panama, Rep. of Panama

Phone: +507 306-2601
Fax: +507 306-2601

About Translational Biosciences
A subsidiary of Medistem Panama Inc., Translational Biosciences was founded solely to conduct clinical trials using adult stem cells and adult stem cell-derived products.

Translational Biosciences webSite: http://www.translationalbiosciences.com

Email: trials(at)translationalbiosciences(dot)com

Sam Harrell’s Stem Cell Journey: Stem Cell Therapy for Multiple Sclerosis

Sam Harrell sent us this homemade video documenting his progress from 2010 until now (2014). Sam was coaching football at Ennis high school in Texas when MS struck him hard, forcing him to retire. Since then, after several rounds of stem cell therapy at the Stem Cell Institute in Panama, Sam has returned to coaching football, something he though that he would never be able to do again.

For more information about umbilical cord tissue-derived mesenchymal stem cell therapy for MS, please visit: http://www.cellmedicine.com/stem-cell-therapy-for-multiple-sclerosis-3/

Umbilical Cord Stem Cell Therapy Clinical Trial for Multiple Sclerosis Gets Green Light

Translational Biosciences Site Header

Dallas, TX (PRWEB) April 03, 2014

Translational Biosciences, a subsidiary of Medistem Panama, has received the green light for a phase I/II clinical trial using human umbilical cord-derived mesenchymal stem cells (UC-MSC) for multiple sclerosis from the Comité Nacional de Bioética de la Investigación (CNEI) Institutional Review Board (IRB) in Panama.

According to the US National Multiple Sclerosis Society, in Multiple Sclerosis (MS), an abnormal immune-mediated T cell response attacks the myelin coating around nerve fibers in the central nervous system, as well as the nerve fibers themselves. This causes nerve impulses to slow or even halt, thus producing symptoms of MS that include fatigue; bladder and bowel problems; vision problems; and difficulty walking. The Cleveland Clinic reports that MS affects more than 350,000 people in the United States and 2.5 million worldwide.

Mesenchymal stem cells harvested from donated human umbilical cords after normal, healthy births possess anti-inflammatory and immune modulatory properties that may relieve MS symptoms. Because these cells are immune privileged, the recipient’s immune system does not reject them. These properties make UC-MSC interesting candidates for the treatment of multiple sclerosis and other autoimmune disorders.

Each patient will receive seven intravenous injections of UC-MSC over the course of 10 days. They will be assessed at 3 months and 12 months primarily for safety and secondarily for indications of efficacy.

The stem cell technology being utilized in this trial was developed by Neil Riordan, PhD, founder of Medistem Panama. The stem cells will be harvested and processed at Medistem Panama’s 8000 sq. ft. ISO-9001 certified laboratory in the prestigious City of Knowledge. They will be administered at the Stem Cell Institute in Panama City, Panama.

From his research laboratory in Dallas, Texas, Dr. Riordan commented, “Umbilical cord tissue provides an abundant, non-controversial supply of immune modulating mesenchymal stem cells. Preclinical and clinical research has demonstrated the anti-inflammatory and immune modulating effects of these cells. We look forward to the safety and efficacy data that will be generated by this clinical trial; the first in the western hemisphere testing the effects of umbilical cord mesenchymal stem cells on patients with multiple sclerosis.”

The Principle Investigator is Jorge Paz-Rodriguez, MD. Dr. Paz-Rodriguez also serves as the Medical Director at the Stem Cell Institute.

For detailed information about this clinical trial visit http://www.clinicaltrials.gov . If you are a multiple sclerosis patient between the ages of 18 and 55, you may qualify for this trial. Please email trials (at) translationalbiosciences (dot) com for more information about how to apply.

About Translational Biosciences

A subsidiary of Medistem Panama Inc., Translational Biosciences was founded solely to conduct clinical trials using adult stem cells and adult stem cell-derived products.

Translational Biosciences Web Site: http://www.translationalbiosciences.com
Email: trials@translationalbiosciences.com

About Medistem Panama Inc.

Since opening its doors in 2007, Medistem Panama Inc. has developed adult stem cell-based products from human umbilical cord tissue and blood, adipose (fat) tissue and bone marrow. Medistem operates an 8000 sq. ft. ISO 9001-certified laboratory in the prestigious City of Knowledge. The laboratory is fully licensed by the Panamanian Ministry of Health and features 3 class 10000 clean rooms, class 100 laminar flow hoods, and class 100 incubators.

Medistem Panama Inc.
Ciudad del Saber, Edif. 221 / Clayton
Panama, Rep. of Panama

Phone: +507 306-2601
Fax: +507 306-2601

About Stem Cell Institute Panama

Founded in 2007 on the principles of providing unbiased, scientifically sound treatment options; the Stem Cell Institute has matured into the world’s leading adult stem cell therapy and research center. In close collaboration with universities and physicians world-wide, our comprehensive stem cell treatment protocols employ well-targeted combinations of autologous bone marrow stem cells, autologous adipose stem cells, and donor human umbilical cord stem cells to treat: multiple sclerosis, spinal cord injury, osteoarthritis, rheumatoid arthritis, heart disease, and autoimmune diseases. To-date, the Institute has treated over 2000 patients.

For more information on stem cell therapy:
Stem Cell Institute Website: http://www.cellmedicine.com

Stem Cell Institute
Via Israel & Calle 66
Plaza Pacific Office #2A
Panama City, Panama